The Genome Clinic: A Multidisciplinary Approach to Assessing the Opportunities and Challenges of Integrating Genomic Analysis into Clinical Care

被引:30
作者
Bowdin, Sarah [1 ,2 ,3 ]
Ray, Peter N. [2 ,4 ,5 ,6 ]
Cohn, Ronald D. [1 ,2 ,3 ,5 ,6 ]
Meyn, M. Stephen [1 ,2 ,3 ,5 ,6 ]
机构
[1] Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Ctr Genet Med, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Dept Paediat, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada
[5] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada
[6] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada
关键词
next-generation sequencing; incidental findings; ethical concerns; health policy; INCIDENTAL FINDINGS; GENETIC-VARIANTS; EXOME; RECOMMENDATIONS; SUSCEPTIBILITY; PENETRANCE; PARTICIPANTS; DIAGNOSIS; CHILDREN; MUTATION;
D O I
10.1002/humu.22536
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Our increasing knowledge of how genomic variants affect human health and the falling costs of whole-genome sequencing are driving the development of individualized genetic medicine. This new clinical paradigm uses knowledge of an individual's genomic variants to guide health care decisions throughout life, to anticipate, diagnose, and manage disease. While individualized genetic medicine offers the promise of transformative change in health care, it forces us to reconsider existing ethical, scientific, and clinical paradigms. The potential benefits of presymptomatic identification of at risk individuals, improved diagnostics, individualized therapy, accurate prognosis, and avoidance of adverse drug reactions coexist with the potential risks of uninterpretable results, psychological harm, outmoded counseling models, and increased health care costs. Here, we review the challenges of integrating genomic analysis into clinical practice and describe a prototype for implementing genetic medicine. Our multidisciplinary team of bioinformaticians, health economists, ethicists, geneticists, genetic counselors, and clinicians has designed a Genome Clinic research project that addresses multiple challenges in genomic medicineranging from the development of bioinformatics tools for the clinical assessment of genomic variants and the discovery of disease genes to health policy inquiries, assessment of clinical care models, patient preference, and the ethics of consent.
引用
收藏
页码:513 / 519
页数:7
相关论文
共 40 条
  • [11] Dorey E., 2013, NAT BIOTECHNOL, V31, P948
  • [12] Actionable, Pathogenic Incidental Findings in 1,000 Participants' Exomes
    Dorschner, Michael O.
    Amendola, Laura M.
    Turner, Emily H.
    Robertson, Peggy D.
    Shirts, Brian H.
    Gallego, Carlos J.
    Bennett, Robin L.
    Jones, Kelly L.
    Tokita, Mari J.
    Bennett, James T.
    Kim, Jerry H.
    Rosenthal, Elisabeth A.
    Kim, Daniel S.
    Tabor, Holly K.
    Bamshad, Michael J.
    Motulsky, Arno G.
    Scott, C. Ronald
    Pritchard, Colin C.
    Walsh, Tom
    Burke, Wylie
    Raskind, Wendy H.
    Byers, Peter
    Hisama, Fuld M.
    Nickerson, Deborah A.
    Jarvik, Gail P.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 93 (04) : 631 - 640
  • [13] Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study
    Facio, Flavia M.
    Eidem, Haley
    Fisher, Tyler
    Brooks, Stephanie
    Linn, Amy
    Kaphingst, Kimberly A.
    Biesecker, Leslie G.
    Biesecker, Barbara B.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (03) : 261 - 265
  • [14] Savant Genome Browser 2: visualization and analysis for population-scale genomics
    Fiume, Marc
    Smith, Eric J. M.
    Brook, Andrew
    Strbenac, Dario
    Turner, Brian
    Mezlini, Aziz M.
    Robinson, Mark D.
    Wodak, Shoshana J.
    Brudno, Michael
    [J]. NUCLEIC ACIDS RESEARCH, 2012, 40 (W1) : W615 - W621
  • [15] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    Ford, D
    Easton, DF
    Stratton, M
    Narod, S
    Goldgar, D
    Devilee, P
    Bishop, DT
    Weber, B
    Lenoir, G
    Chang-Claude, J
    Sobol, H
    Teare, MD
    Struewing, J
    Arason, A
    Scherneck, S
    Peto, J
    Rebbeck, TR
    Tonin, P
    Neuhausen, S
    Barkardottir, R
    Eyfjord, J
    Lynch, H
    Ponder, BAJ
    Gayther, SA
    Birch, JM
    Lindblom, A
    Stoppa-Lyonnet, D
    Bignon, Y
    Borg, A
    Hamann, U
    Haites, N
    Scott, RJ
    Maugard, CM
    Vasen, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 676 - 689
  • [16] Evaluating the utility of personal genomic information
    Foster, Morris W.
    Mulvihill, John J.
    Sharp, Richard R.
    [J]. GENETICS IN MEDICINE, 2009, 11 (08) : 570 - 574
  • [17] Genome sequencing: A systematic review of health economic evidence
    Frank M.
    Prenzler A.
    Eils R.
    von der Schulenburg J.-M.G.
    [J]. Health Economics Review, 3 (1) : 1 - 8
  • [18] PhenoTips: Patient Phenotyping Software for Clinical and Research Use
    Girdea, Marta
    Dumitriu, Sergiu
    Fiume, Marc
    Bowdin, Sarah
    Boycott, Kym M.
    Chenier, Sebastien
    Chitayat, David
    Faghfoury, Hanna
    Meyn, M. Stephen
    Ray, Peter N.
    So, Joyce
    Stavropoulos, Dimitri J.
    Brudno, Michael
    [J]. HUMAN MUTATION, 2013, 34 (08) : 1057 - 1065
  • [19] Performance of computational tools in evaluating the functional impact of laboratory-induced amino acid mutations
    Gray, Vanessa E.
    Kukurba, Kimberly R.
    Kumar, Sudhir
    [J]. BIOINFORMATICS, 2012, 28 (16) : 2093 - 2096
  • [20] ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
    Green, Robert C.
    Berg, Jonathan S.
    Grody, Wayne W.
    Kalia, Sarah S.
    Korf, Bruce R.
    Martin, Christa L.
    McGuire, Amy L.
    Nussbaum, Robert L.
    O'Daniel, Julianne M.
    Ormond, Kelly E.
    Rehm, Heidi L.
    Watson, Michael S.
    Williams, Marc S.
    Biesecker, Leslie G.
    [J]. GENETICS IN MEDICINE, 2013, 15 (07) : 565 - 574